Historical record - last NADAC publication: 4/17/2024
Product Information
AMLODIPINE-OLMESARTAN 5-40 MG is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.2788 per EA under NDC 68462056830. Its NADAC has been published 222 times since Feb 19, 2020.
The High Outlier badge above means this manufacturer's average price in the Amlodipine and Olmesartan Medoxomil market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5; 40 mg/1; mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462056830
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
4/17/2024
Active Ingredients
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA207807On Market Since
7/5/2017
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-OLMESARTAN 5-40 MG has been published 222 times since Feb 19, 2020, and over the history we have for it it has declined 65.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2788 per EA |
|---|---|
| All-time high | $0.9091 (Jun 10, 2020) |
| All-time low | $0.2788 (Apr 17, 2024) |
| Median price | $0.4391 |
| Average price | $0.4947 |
| Largest weekly change | -45.3% (Nov 18, 2020) |
| Weeks tracked | 222 |
| Tracking since | Feb 19, 2020 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of AMLODIPINE-OLMESARTAN 5-40 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 5-40 MG, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.2788 per EA (NDC 68462056830), effective May 15, 2024.
How has the price of AMLODIPINE-OLMESARTAN 5-40 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 5-40 MG has declined 65.1%. It has been tracked across 222 weekly CMS publications since Feb 19, 2020.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 5-40 MG?
Since Feb 19, 2020, the NADAC for AMLODIPINE-OLMESARTAN 5-40 MG has ranged from a low of $0.2788 (Apr 17, 2024) to a high of $0.9091 (Jun 10, 2020), with a median of $0.4391 per EA.
Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 5-40 MG?
4 NADAC-published products share the same active ingredient, strength, and dosage form as AMLODIPINE-OLMESARTAN 5-40 MG, but none are currently priced below it.
Who manufactures AMLODIPINE-OLMESARTAN 5-40 MG?
AMLODIPINE-OLMESARTAN 5-40 MG (NDC 68462056830) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification